iifl-logo

Quant Healthcare Fund Regular G

Quant Healthcare Fund Regular G

Fund Name

Quant Mutual Fund

Scheme Name

Quant Healthcare Fund Regular G

AMC

Quant Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

27-Jun-2023

Fund Manager

Sandeep Tandon

Net Assets (Rs. cr)

378.53

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Quant Healthcare Fund Regular G - Nav Details

Nav Date

:  12-Dec-2025

NAV [Rs.]

:  15.1136

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Quant Healthcare Fund Regular G- NAV Chart

Quant Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.6
-1.93
-3.97
-4.25
-6.75
-
-
18.42
Category Avg
-0.97
-0.99
-1.76
0.86
-0.97
22.59
16.46
14.15
Category Best
-0.57
0.34
0.69
5.12
5.78
28.24
19.42
29.91
Category Worst
-1.48
-2.21
-3.97
-4.25
-8.14
18.7
12.33
-5.22

Quant Healthcare Fund Regular G- Latest Dividends

No Records Found

Quant Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Lupin56,976

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySMS Pharma.Pharmaceuticals & Biotechnology9.65114521736.55
EquitySequent Scien.Pharmaceuticals & Biotechnology8.72147712633.00
EquityAster DM Health.Healthcare Services7.8544667129.72
EquityZydus WellnessFood Products7.2964173027.62
EquityAurobindo PharmaPharmaceuticals & Biotechnology7.0421730026.65
EquityPfizerPharmaceuticals & Biotechnology6.304795423.85
EquityAlivus LifePharmaceuticals & Biotechnology5.8424629822.12
EquityAdani Enterp.Metals & Minerals Trading5.729499621.66
EquityAnthem BiosciencPharmaceuticals & Biotechnology5.5933355421.17
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology4.809921418.17
EquityDivi's Lab.Pharmaceuticals & Biotechnology3.492042413.22
EquityConcord BiotechPharmaceuticals & Biotechnology3.128347211.83
EquityGodrej Propert.Realty2.62470159.94
EquityGland PharmaPharmaceuticals & Biotechnology1.30280764.94
RightsAdani Enterp.N.A.0.13113990.50

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Quant Mutual Fund
Incorporation Date:
01-Dec-1995
Total Assets Managed (Cr.):
96,240.54
Trustee/s:
Quant Capital Trustee Lim, Mr. Deba Prasad Roy
Chairman:
NA
CEO / MD:
Mr. Sandeep Tandon
CIO:
NA
President:
NA
Director/s:
Mr. Deep Shukla, Mr.Vasav Sahgal, Sandeep Tandon, Mr. Laxmikant Gupta, Mr. Sandeep Tandon, Mr. Deep Shukla, Mr. Bhaskar Sharma
Compliance Officer/s:
Ms. Usha Lakshmi Raman
Investor Service Officer/s:
Mr. Shardul Gusain
Fund Manager/s:
Sandeep Tandon
Auditors:
M M Nissim & Co LLP

OTHER INFORMATION

Registered Office:
6th Floor, Sea Breeze Building, Appasaheb Marathe Marg, Prabhadevi Mumbai - 400025
Contact Nos:
022-62955000
Fax:
NA
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.